pregabalin has been researched along with Myalgia* in 5 studies
1 trial(s) available for pregabalin and Myalgia
Article | Year |
---|---|
The Effect of Pregabalin on the Prevention of Succinylcholine-Induced Fasciculation and Myalgia.
This study evaluates the effect of pregabalin on fasciculation and myalgia after using succinylcholine.. This randomized double-blind prospective study was conducted among 100 patients aged 20 to 60 years old.. Pregabalin (300 mg) and placebo (in capsule form) were placed in similar containers. The results were analyzed by SPSS 23 software, and statistical analysis consisted of χ. This study showed that 300 mg of pregabalin was effective in reducing postoperative fasciculation and myalgia in patients treated with succinylcholine. Topics: Adult; Double-Blind Method; Fasciculation; Humans; Middle Aged; Myalgia; Neuromuscular Depolarizing Agents; Pregabalin; Prospective Studies; Succinylcholine; Young Adult | 2020 |
4 other study(ies) available for pregabalin and Myalgia
Article | Year |
---|---|
Dry needling increases antioxidant activity and grip force in a rat model of muscle pain.
Muscle pain syndromes (MPS) are one of the main causes of functional, structural and metabolic problems, being associated with tissue oxidative damage. Although dry needling is widely used in the treatment of MPS, there is little scientific evidence of its efficacy and underlying mechanisms of action.. To investigate the effects of different dry needling techniques on thermal and mechanical hyperalgesia, locomotor and functional activity, and oxidative stress markers in a rat model of muscle pain.. A total of 48 male Wistar rats underwent injection of the gastrocnemius muscle with control neutral saline (pH 7) and remained untreated (Saline group), or acidic saline (pH 4) and remained untreated (ASA group) or received pregabalin (PG group), deep needling (DN group), superficial needling (SN group) or twitch needling (TN group) with n = 8 rats per group. Mechanical (von Frey test) and thermal hyperalgesia (acetone test), muscle edema (assessed with a caliper), strength and muscle function (grip force evaluation), surface thermography and locomotor and exploratory activities (open field test) were evaluated. The animals were then euthanized, and the gastrocnemius muscle was excised for assessment of oxidative analyses of lipid peroxidation with thiobarbituric acid reactive species (TBA-RS) and total glutathione (GSH) levels.. All treatments significantly improved muscle strength and function when compared to the AS group (p < 0.05). Pregabalin reduced locomotor and exploratory activities, while the TN intervention increased the antioxidant response (p < 0.05).. Dry needling improved strength, functionality and locomotor activity in a rat model of muscle pain. Twitch needling induced an antioxidant effect. Topics: Animals; Antioxidants; Dry Needling; Female; Hand Strength; Hyperalgesia; Male; Myalgia; Pregabalin; Rats; Rats, Wistar; Trigger Points | 2022 |
Response to "The Effect of Pregabalin on the Prevention of Succinylcholine-Induced Fasciculation and Myalgia".
Topics: Fasciculation; Humans; Myalgia; Pain, Postoperative; Pregabalin; Succinylcholine | 2021 |
Reply to Abdulzahra.
Topics: Fasciculation; Humans; Myalgia; Pregabalin; Succinylcholine | 2021 |
Chronic Pregabalin Treatment Ameliorates Pain, but not Depressive-Like Behaviors, in a Reserpine-Induced Myalgia Model in Rats.
Anticonvulsants are often prescribed as coanalgesics for pathologies presenting chronic pain, such as chronic neuropathic pain and fibromyalgia. These pathologies are associated with a wide range of comorbidities: chronic fatigue, cognitive impairment, sleep disturbances, and mood disorders. Pregabalin, an anticonvulsant used to treat fibromyalgia syndrome, has been proven to improve pain and fatigue symptoms. However, most studies have not considered the analytic effect of this drug on comorbid depressive-like symptoms in this syndrome.. The main study objective was to examine the role of pregabalin in depressive symptomatology comorbid to chronic widespread pain using a reserpine-induced myalgia model.. A randomized, controlled, animal study.. Research and data analyses were performed at the GESADA laboratory, Department of Human Anatomy and Embryology, University of Valencia, Spain.. Forty-six Sprague-Dawley male rats were used. Acute chronic pregabalin administration was tested for depressive-like behaviors (Forced Swimming and Novelty-Suppressed Feeding Tests) and for alteration of pain thresholds (tactile allodynia, Electronic Von Frey test; and mechanical hyperalgesia, Randall and Selitto test). The same procedures were followed with duloxetine as a positive control.. Pregabalin significantly improved depressive-like behaviors in acute, but not chronic treatment, and significantly ameliorated pain thresholds.. Lack of histological and electrophysiological tests.. Pregabalin is not effective in depressive-like symptoms associated with chronic pain but might play an acute antidepressive-like role given its antinociceptive effect. Topics: Animals; Anticonvulsants; Antihypertensive Agents; Chronic Pain; Depression; Disease Models, Animal; Drug Administration Schedule; Male; Myalgia; Pain Threshold; Pregabalin; Random Allocation; Rats; Rats, Sprague-Dawley; Reserpine; Treatment Outcome | 2020 |